Panama Medical Device Registration Roadmap: Ten Steps, Three Deadlines
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The compliance chain for entering the Panamanian market breaks into ten steps: classification of the product, risk grading, fixing the local licence holder and operator, obtaining the operating licence, preparing the Spanish technical and legal documents, completing apostille or consular legalisation, filing the CCT application, handling review and corrections, configuring labelling and import information, and building the vigilance and reporting system. The chain contains three official time limits: 45 working days for the operating licence (Article 20 of DE 490), 30 working days for the CCT (Article 24) and 60 working days for corrections (Article 24, second paragraph). Those three are response deadlines for the authority, not the time to certificate, so a project schedule has to add the correction round trip on top.
- Three of the ten steps are preconditions, and getting their order wrong forces rework across the whole file.
- The official deadlines and the achievable timeline are two different quantities and must be tracked separately.
- Legalisation, not translation, is the bottleneck in the document chain.
- Step ten is the start of the post-market phase, not the end of the project.
2. Legal basis
Each step rests on a specific provision, and the table below maps them. Reading it as a sequence is useful, because several steps depend on the output of the one before, and the dependencies are what make the order non-negotiable.
| 1 Classification | Ley N° 90, Article 6, definitions 14, 16 and 21; Articles 1, 5 and 11 | Device, IVD, biomedical equipment or related product; exclusion of medicines and borderline consultation |
| 2 Risk grading | DE 490, Article 30; Ley N° 90, Article 16 | Four classes A, B, C and D; most current GHTF and IMDRF version; higher class where two apply |
| 3 Parties | Ley N° 90, Article 6, definitions 24 and 37; DE 490, Article 2, definitions 90 and 91 | Distinction between manufacturer, supplier, product holder and registration holder |
| 4 Operating licence | DE 490, Articles 12 to 20 (Article 17 as amended by DE 416) | Five licence types; 5-year validity; 45 working days for approval; renewal 60 working days before expiry |
| 5 Technical and legal documents | DE 490, Article 36 (as amended by DE 416) and Article 37 | 13 general items plus special requirements that escalate with risk |
| 6 Legalisation and translation | DE 490, Article 35 | Apostille (Ley No. 6 of 1990) or consular legalisation; documents not in Spanish translated by a Panamanian public authorised translator; catalogue exemption |
| 7 Filing | DE 490, Articles 23 and 24 | One file per product or per family; 30 working days for a response |
| 8 Corrections | DE 490, Article 24, second and third paragraphs | Correction period of 60 working days; a further 30 working days after supplementation |
| 9 Labelling and import | DE 490, Articles 38, 39 and 40; Ley N° 90, Articles 27 and 28 | Instructions for use 17 items; labelling 12 items; relabelling prohibited; import information 12 items; duty exemption |
| 10 Vigilance | DE 490, Articles 45 to 62; Ley N° 90, Articles 29 to 33 | Serious incidents reported within 72 hours; recalls require prior approval; implantable devices must be traceable |
3. Expert insights
Insight one: three of the ten steps are preconditions, and a wrong order forces a full restart. Step one fixes which licence category is needed at step four, whether manufacturing, conditioning, distribution, retail or warehousing. Step two fixes the document list at step five and the review format at step seven, since the specialist assessment requirement differs between classes A and B on one side and C and D on the other. Step three fixes who may file and who may hold the certificate. If any of the three is settled late, the work already done in front of it has to be redone in a different direction.
Insight two: official deadlines and real timelines are two quantities that must be managed separately. Article 20 of DE 490 gives 45 working days for the operating licence and Article 24 gives 30 working days for the CCT, and both are response deadlines counted from acceptance. The second paragraph of Article 24 adds 60 working days for corrections, and the third paragraph restarts a further 30 working days after the correction is filed. A single correction round therefore pushes the timeline from 30 working days to 30 plus 60 plus 30, which is 120 working days or more. Treating the response deadline as the certificate timeline is the main cause of schedules that slip without anyone being able to say why.
Insight three: the bottleneck in the document chain is legalisation, not translation. Article 35 requires foreign legal documents to carry an apostille, Panama having acceded by Ley No. 6 of 25 June 1990, or consular legalisation, and documents not in Spanish to be translated by a Panamanian public authorised translator. The apostille involves the competent authority of the country of origin, and its duration is outside the applicant’s control; translation is done locally in Panama and is comparatively predictable. The certification step belongs on the critical path from the start, not at the end in parallel with document drafting.
Insight four: step ten is the beginning of the second phase, not the finish line. DE 490 builds the vigilance system across 18 articles from Article 45 onwards, and Articles 29 to 33 of Ley 90 add further duties. Reporting serious incidents within 72 hours (Article 56), periodic reporting (Article 57), prior approval of recalls (Article 58) and mandatory traceability for implantable devices (Article 62) are continuing obligations. A compliance budget that stops at certification leaves a responsibility vacuum in the phase where the obligations actually keep running.
4. Practical recommendations
- At the kick-off meeting, complete classification, risk grading and party arrangements first, and put the conclusions in writing before document preparation begins.
- Show the official response deadlines and the correction window as separate lines in the schedule, and estimate the total at no fewer than one correction round.
- Set up legalisation as its own workstream and start it early, rather than waiting for the documents to be complete.
- Build an item-by-item check table for labels and instructions for use against Articles 38 and 40 of DE 490, and do not accept over-stickering of the country-of-origin label.
- Start building the vigilance system at the same time as certification, name the responsible person and rehearse the reporting flow.
5. Verification checklist
- □ Classification conclusion documented in writing with the provisions relied on
- □ Risk class determined and the GHTF or IMDRF version recorded
- □ Local licence holder and operator determined, with the licence category matched
- □ Licence application filed and the 45 working day milestone being tracked
- □ Document list checked item by item against Articles 36 and 37
- □ Legalisation and translation status of foreign documents confirmed
- □ CCT submission logged with the 30 working day milestone
- □ Label and instructions for use checked against Articles 38 and 40, with no over-stickering
- □ The 12 import information items written into the invoice template
- □ Vigilance owner named and the 72 hour reporting flow rehearsed
Regulatory information verified to 29 October 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registrations through the DIGEMID-equivalent medical device directorate, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us